Astrana Health, Inc. (ASTH) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $38.23 (-0.40%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Dec 12, 2025 | Matthew Shea | Needham | $28.00 | -26.7% |
| Nov 24, 2025 | Andrew Mok | Barclays | $26.00 | -32.0% |
| Oct 3, 2024 | David Larsen | BTIG | $70.00 | +83.1% |
| Aug 15, 2024 | Michael Ha | Robert W. Baird | $67.00 | +75.3% |
| Jun 27, 2024 | Chris O'Cull | Stifel Nicolaus | $48.00 | +25.6% |
Top Analysts Covering ASTH
ASTH vs Sector & Market
| Metric | ASTH | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.10 | 2.24 | 2.40 |
| Analyst Count | 10 | 8 | 19 |
| Target Upside | +16.5% | +11475.0% | +17.1% |
| P/E Ratio | 83.55 | 3.83 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $925M | $980M | $1.01B | 6 |
| 2026-09-30 | $992M | $1.03B | $1.05B | 4 |
| 2026-12-31 | $998M | $1.03B | $1.06B | 5 |
| 2027-03-31 | $1.02B | $1.06B | $1.08B | 3 |
| 2027-06-30 | $1.05B | $1.08B | $1.11B | 3 |
| 2027-09-30 | $1.11B | $1.15B | $1.18B | 3 |
| 2027-12-31 | $1.11B | $1.15B | $1.18B | 3 |
| 2028-12-31 | $4.48B | $4.64B | $4.83B | 1 |
| 2029-12-31 | $4.84B | $5.02B | $5.22B | 1 |
| 2030-12-31 | $5.22B | $5.41B | $5.63B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.18 | $0.34 | $0.49 | 1 |
| 2026-09-30 | $0.34 | $0.36 | $0.37 | 1 |
| 2026-12-31 | $0.23 | $0.24 | $0.25 | 1 |
| 2027-03-31 | $0.42 | $0.44 | $0.45 | 1 |
| 2027-06-30 | $0.41 | $0.43 | $0.44 | 1 |
| 2027-09-30 | $0.46 | $0.48 | $0.50 | 1 |
| 2027-12-31 | $0.32 | $0.33 | $0.34 | 1 |
| 2028-12-31 | $2.11 | $2.21 | $2.33 | 1 |
| 2029-12-31 | $2.68 | $2.81 | $2.96 | 1 |
| 2030-12-31 | $3.24 | $3.40 | $3.58 | 1 |
Frequently Asked Questions
What is the analyst consensus for ASTH?
The consensus among 10 analysts covering Astrana Health, Inc. (ASTH) is Buy with an average price target of $37.80.
What is the highest price target for ASTH?
The highest price target for ASTH is $70.00, set by David Larsen at BTIG on 2024-10-03.
What is the lowest price target for ASTH?
The lowest price target for ASTH is $26.00, set by Andrew Mok at Barclays on 2025-11-24.
How many analysts cover ASTH?
10 analysts have issued ratings for Astrana Health, Inc. in the past 12 months.
Is ASTH a buy or sell right now?
Based on 10 analyst ratings, ASTH has a consensus rating of Buy (2.10/5) with a +16.5% upside to the consensus target of $37.80.
What are the earnings estimates for ASTH?
Analysts estimate ASTH will report EPS of $0.34 for the period ending 2026-06-30, with revenue estimated at $980M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.